These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11161630)

  • 1. Antiparkinsonian and behavioral effects of inactivation of the substantia nigra pars reticulata in hemiparkinsonian primates.
    Wichmann T; Kliem MA; DeLong MR
    Exp Neurol; 2001 Feb; 167(2):410-24. PubMed ID: 11161630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postural changes after lesions of the substantia nigra pars reticulata in hemiparkinsonian monkeys.
    Henderson JM; Stanic D; Tomas D; Patch J; Horne MK; Bourke D; Finkelstein DI
    Behav Brain Res; 2005 May; 160(2):267-76. PubMed ID: 15863223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lesions in monkey globus pallidus externus exacerbate parkinsonian symptoms.
    Zhang J; Russo GS; Mewes K; Rye DB; Vitek JL
    Exp Neurol; 2006 Jun; 199(2):446-53. PubMed ID: 16487515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spontaneous saccades in MPTP-induced hemi-parkinsonian monkeys].
    Usui S; Fukuda H; Hikosaka O
    Rinsho Shinkeigaku; 1990 Nov; 30(11):1181-9. PubMed ID: 2085922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fos expression following activation of the ventral pallidum in normal rats and in a model of Parkinson's Disease: implications for limbic system and basal ganglia interactions.
    Turner MS; Gray TS; Mickiewicz AL; Napier TC
    Brain Struct Funct; 2008 Sep; 213(1-2):197-213. PubMed ID: 18663473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia.
    Nevet A; Morris G; Saban G; Fainstein N; Bergman H
    J Neurophysiol; 2004 Oct; 92(4):1973-81. PubMed ID: 15115785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of transient focal inactivation of the basal ganglia in parkinsonian primates.
    Baron MS; Wichmann T; Ma D; DeLong MR
    J Neurosci; 2002 Jan; 22(2):592-9. PubMed ID: 11784807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The primate subthalamic nucleus. III. Changes in motor behavior and neuronal activity in the internal pallidum induced by subthalamic inactivation in the MPTP model of parkinsonism.
    Wichmann T; Bergman H; DeLong MR
    J Neurophysiol; 1994 Aug; 72(2):521-30. PubMed ID: 7983516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease.
    Greenamyre JT; Eller RV; Zhang Z; Ovadia A; Kurlan R; Gash DM
    Ann Neurol; 1994 Jun; 35(6):655-61. PubMed ID: 8210221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism.
    Filion M; Tremblay L; Bédard PJ
    Brain Res; 1991 Apr; 547(1):152-61. PubMed ID: 1677608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a role of basal ganglia in the regulation of rapid eye movement sleep by electrical and chemical stimulation for the pedunculopontine tegmental nucleus and the substantia nigra pars reticulata in decerebrate cats.
    Takakusaki K; Saitoh K; Harada H; Okumura T; Sakamoto T
    Neuroscience; 2004; 124(1):207-20. PubMed ID: 14960352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion.
    Sindhu KM; Saravanan KS; Mohanakumar KP
    Brain Res; 2005 Jul; 1051(1-2):25-34. PubMed ID: 15992782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates.
    Wichmann T; Bergman H; Starr PA; Subramanian T; Watts RL; DeLong MR
    Exp Brain Res; 1999 Apr; 125(4):397-409. PubMed ID: 10323285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys.
    Kliem MA; Maidment NT; Ackerson LC; Chen S; Smith Y; Wichmann T
    J Neurophysiol; 2007 Sep; 98(3):1489-500. PubMed ID: 17634344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 125I-CGP 64213 binding to GABA(B) receptors in the brain of monkeys: effect of MPTP and dopaminomimetic treatments.
    Calon F; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
    Exp Neurol; 2000 May; 163(1):191-9. PubMed ID: 10785458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
    Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G
    Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.
    Mash DC; Sanchez-Ramos J; Weiner WJ
    Adv Neurol; 1993; 60():133-9. PubMed ID: 8420130
    [No Abstract]   [Full Text] [Related]  

  • 20. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model.
    Breit S; Lessmann L; Unterbrink D; Popa RC; Gasser T; Schulz JB
    Eur J Neurosci; 2006 Oct; 24(8):2275-82. PubMed ID: 17042796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.